InMed Pharmaceuticals Inc. Cash Flow Statement

Cash Flow Statement Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Operating Activities
Net Income -18.60M-7.95M-7.68M-8.16M
Depreciation and Depletion 0.03M0.04M0.05M0.05M
Share-based Compensation 0.99M0.61M0.70M0.28M0.14M0.12M
Gains from Investment Securities 0.01M0.06M0.10M0.03M0.06M
Asset Writedowns and Impairment 3.47M0.31M0.31M0.00M
Non-cash Items 0.18M0.07M
Cash from Operations -7.37M-9.79M-15.58M-7.28M-6.99M-7.77M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.33M0.39M0.38M0.32M
Depreciation & Amortization (CF) 0.11M0.12M0.19M0.20M0.22M0.21M
Change in Working Capital
Change in Receivables -0.02M-0.04M0.04M0.22M0.09M0.11M
Change in Inventory 2.00M-0.57M-0.07M-0.28M
Change in Accured Expenses 0.47M0.35M-0.81M-0.81M0.05M-0.25M
Other Working Capital Changes 0.13M0.82M-0.19M-0.43M-0.40M-0.43M
Investing Activities
Capital Expenditures 0.04M0.00M0.04M0.16M0.01M
Sales of Property, Plant and Equipment 541.00
Acquisitions 0.50M
Change in Acquisitions & Divestments 3.88M0.04M0.04M0.04M
Cash from Investing Activities 3.79M-0.00M-0.67M-0.66M-0.01M
Financing Activities
Other financing activities 0.03M1.62M1.78M1.32M0.56M0.88M
Cash from Financing Activities -0.03M10.85M15.07M10.68M4.65M12.27M
Additional items
Exchange Rate Effect -0.42M0.49M
Change in Cash -4.03M1.56M-1.19M2.74M-2.34M4.50M
Beginning Cash Balance 4.03M-1.56M7.36M6.18M8.91M6.57M
Free Cash Flow -7.42M-9.79M-15.62M-7.44M-7.00M-7.77M
Net Cash Flow -3.62M1.06M-1.19M2.74M-2.34M4.50M